Search
for

    Sort by

    Research 181–210 of 1000+

    1. Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areata PNAS nexus · 2022 · 2 citations
    2. An urticarial drug eruption caused by tofacitinib for alopecia universalis Dermatologic Therapy · 2019 · 2 citations
    3. Improvement of Recalcitrant Dissecting Cellulitis of the Scalp After a Trial of Upadacitinib Curēus · 2024 · 1 citations
    4. Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata JAMA Dermatology · 2023 · 1 citations
    5. A Case of Tofacitinib for the Treatment of Resistant Vitiligo and Sustained Repigmentation After Discontinuation Research Square (Research Square) · 2023 · 1 citations
    6. Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib Cutis · 2023 · 1 citations
    7. 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss Journal of The American Academy of Dermatology · 2022 · 1 citations
    8. LB943 Tofacitinib treatment of inflammatory skin conditions in patients with Down Syndrome 2022 · 1 citations
    9. POS0080 TOFACITINIB TREATMENT IN CHILDREN WITH RHEUMATIC DISEASES: SINGLE-CENTER EXPERIENCE Annals of the rheumatic diseases · 2021 · 1 citations
    10. Alopecia universalis. Partial response to tofacitinib Medicina Clínica (English Edition) · 2019 · 1 citations
    11. High throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in Alopecia Areata immuneACCESS · 2018 · 1 citations
    12. 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms Journal of Investigative Dermatology · 2018 · 1 citations
    13. Treatment of severe alopecia areata with oral tofacitinib: A case series Journal of the American Academy of Dermatology · 2017 · 1 citations
    14. Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib Anais Brasileiros de Dermatologia · 2026
    15. Ritlecitinib (Litfulo) Canadian Journal of Health Technologies · 2026
    16. Supplementary Material for: TOFACITINIB IN OVERLAPPING AUTOIMMUNE AND AUTOINFLAMMATORY DISORDERS: A CASE REPORT OF A DUAL GRAHAM-LITTLE-PICCARDI-LASSEUR SYNDROME AND HIDRADENITIS SUPPURATIVA Figshare · 2026
    17. TOFACITINIB IN OVERLAPPING AUTOIMMUNE AND AUTOINFLAMMATORY DISORDERS: A CASE REPORT OF A DUAL GRAHAM-LITTLE-PICCARDI-LASSEUR SYNDROME AND HIDRADENITIS SUPPURATIVA Case Reports in Dermatology · 2026
    18. Supplementary Material for: TOFACITINIB IN OVERLAPPING AUTOIMMUNE AND AUTOINFLAMMATORY DISORDERS: A CASE REPORT OF A DUAL GRAHAM-LITTLE-PICCARDI-LASSEUR SYNDROME AND HIDRADENITIS SUPPURATIVA Figshare · 2026
    19. rwSALT: a regrowth-weighted SALT score providing direct pixel-level measurement rather than visual estimation Mendeley Data · 2026
    20. rwSALT: a regrowth-weighted SALT score providing direct pixel-level measurement rather than visual estimation Mendeley Data · 2026
    21. Complete Reversal of Alopecia Universalis Using Tofacitinib in a Patient with Rheumatoid Arthritis: A Case Report Annals of Case Reports · 2026
    22. Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports Clinical Cosmetic and Investigational Dermatology · 2026
    23. Deuruxolitinib for Alopecia Areata. PubMed · 2026
    24. Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · 2026
    25. A case of dupilumab-induced psoriatic alopecia Skin Health and Disease · 2025
    26. Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients. PubMed · 2025
    27. 470 Exploring the possible involvement of skin-resident memory T cells in refractory chronic alopecia areata Journal of Investigative Dermatology · 2025
    28. Most Baricitinib Responders Achieved Full Scalp Hair Regrowth: Findings from Adult and Paediatric BRAVE-AA Trials SKIN The Journal of Cutaneous Medicine · 2025
    29. Effectiveness of Baricitinib for Nasal, Genital, and Beard Hair Regrowth in Patients with Severe Alopecia Areata: 12-Month Outcomes from a Prospective Observational Study SKIN The Journal of Cutaneous Medicine · 2025
    30. Baricitinib in Dermatology: Expanding Therapeutic Horizons Beyond Alopecia Areata Journal of Skin and Stem Cell · 2025